TELA Bio, Inc. is a high-risk healthcare company in the United States that specializes in developing and marketing tissue reinforcement materials. Their innovative products, such as OviTex and OviTex PRS Reinforced Tissue Matrix, are designed to improve clinical outcomes and reduce costs in soft tissue reconstruction. With an ESG score of 31.8, TELA Bio is dedicated to sustainability and governance practices in the healthcare industry.